Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.51 EUR
665.02 M EUR
28.23 B EUR
1.50 B
About Takeda Pharmaceutical Co. Ltd.
Sector
Industry
CEO
Christophe Weber
Website
Headquarters
Osaka
Founded
1781
ISIN
JP3463000004
FIGI
BBG000BYJS73
Takeda Pharmaceutical Co., Ltd. engages in the research and development, manufacture, import and export sale, and marketing of pharmaceutical drugs. It operates through the following segments: Prescription Drug, Consumer Healthcare, and Other. The Prescription Drugs segment includes the manufacture and sale of pharmaceutical products. The Consumer Healthcare segment includes the manufacture and sale of OTC drugs and quasi-drugs. The Other segment includes manufacture and sale of reagents, clinical diagnostics, and chemical products. The company was founded by Takeda Chobei on June 12, 1781 and is headquartered in Osaka, Japan.
Related stocks
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
TKPH5841810
Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064Yield to maturity
5.78%
Maturity date
Jul 5, 2064
TKPH5010048
Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060Yield to maturity
5.62%
Maturity date
Jul 9, 2060
TKPH5841809
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054Yield to maturity
5.62%
Maturity date
Jul 5, 2054
TKPH5010047
Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050Yield to maturity
5.59%
Maturity date
Jul 9, 2050
TKPH5841808
Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044Yield to maturity
5.42%
Maturity date
Jul 5, 2044
TKPH5010046
Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040Yield to maturity
5.31%
Maturity date
Jul 9, 2040
TKPH5841807
Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034Yield to maturity
4.85%
Maturity date
Jul 5, 2034
TKPH5010045
Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030Yield to maturity
4.30%
Maturity date
Mar 31, 2030
TKPH4770188
Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028Yield to maturity
4.21%
Maturity date
Nov 26, 2028
S
US82481LAD1
Shire Acquisitions Investments Ireland Designated Activity Company 3.2% 23-SEP-2026Yield to maturity
4.18%
Maturity date
Sep 23, 2026
See all TKD bonds
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Takeda Pharmaceutical Co. Ltd. stocks are traded under the ticker TKD.
We've gathered analysts' opinions on Takeda Pharmaceutical Co. Ltd. future price: according to them, TKD price has a max estimate of 34.07 EUR and a min estimate of 25.98 EUR. Watch TKD chart and read a more detailed Takeda Pharmaceutical Co. Ltd. stock forecast: see what analysts think of Takeda Pharmaceutical Co. Ltd. and suggest that you do with its stocks.
Yes, you can track Takeda Pharmaceutical Co. Ltd. financials in yearly and quarterly reports right on TradingView.
Takeda Pharmaceutical Co. Ltd. is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
TKD earnings for the last quarter are 0.47 EUR per share, whereas the estimation was 0.29 EUR resulting in a 60.22% surprise. The estimated earnings for the next quarter are 0.28 EUR per share. See more details about Takeda Pharmaceutical Co. Ltd. earnings.
Takeda Pharmaceutical Co. Ltd. revenue for the last quarter amounts to 6.52 B EUR, despite the estimated figure of 6.87 B EUR. In the next quarter, revenue is expected to reach 6.75 B EUR.
TKD net income for the last quarter is 731.86 M EUR, while the quarter before that showed −635.61 M EUR of net income which accounts for 215.14% change. Track more Takeda Pharmaceutical Co. Ltd. financial stats to get the full picture.
Takeda Pharmaceutical Co. Ltd. dividend yield was 4.44% in 2024, and payout ratio reached 286.73%. The year before the numbers were 4.49% and 204.15% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 7, 2025, the company has 47.45 K employees. See our rating of the largest employees — is Takeda Pharmaceutical Co. Ltd. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Takeda Pharmaceutical Co. Ltd. EBITDA is 7.77 B EUR, and current EBITDA margin is 30.32%. See more stats in Takeda Pharmaceutical Co. Ltd. financial statements.
Like other stocks, TKD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Takeda Pharmaceutical Co. Ltd. stock right from TradingView charts — choose your broker and connect to your account.